Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study)
Date issued
2014Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso